The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., Jan 12, 2014
The primary end--point of the study was to established the role of sestamibi scintimammography an... more The primary end--point of the study was to established the role of sestamibi scintimammography and PET/CT findings in locally advanced breast cancer (LABC) before neoadjuvant systemic therapy (NST) in different histological subtypes. The secondary end--point was to determine the role of FDG PET/CT as multi drug resistance marker. METHODS:From January 2012, we prospectively enrolled 51 consecutive women (median age: 49 years;; range: 27--76 yrs) with a biopsy--proven LABC. All patients underwent both sestamibi scintimammography and FDG PET/CT within one week before to start NST. Both examinations were qualitatively and semiquantitatively analysed. For scintimammography we calculated the tumor to background ratio (T/B) and the most intense uptake of the tumor to background ratio (I/B) according the following formula: T/B=[cntsT--cntsB]/ [cntsB] and I/B [cntsI--cntsB]/ [cntsB]. Furthermore, the percentage washout index (WO) for T and I were obtained, according to: WOT,I= [cntsT,I]early...
Uploads
Papers by Fernando Bozza